Pre-made Gilvetmab benchmark antibody ( Canine Whole mAb, anti-PDCD1 (Canine) therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-243

Pre-Made Gilvetmab biosimilar, Canine Whole Mab: Anti-PDCD1 (Canine) therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-243-1mg 1mg 3090
GMP-Bios-ab-243-10mg 10mg Inquiry
GMP-Bios-ab-243-100mg 100mg Inquiry
GMP-Bios-ab-243-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Gilvetmab biosimilar, Canine Whole Mab: Anti-PDCD1 (Canine) therapeutic antibody
INN Name Gilvetmab
TargetPDCD1 (Canine)
FormatCanine Whole mAb
DerivationCaninized
Species ReactivityCanine
CH1 IsotypeIgG2
VD LCKappa
Highest_Clin_Trial (Jan '20)Unknown
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2016
Year Recommended2017
CompaniesMerck
Conditions Approvedna
Conditions ActiveCanine Cancers
Conditions Discontinuedna
Development Techna